Levokarnytyn | Elkar solution for oral administration 300 mg / ml bottle 50 ml

Latin name

Elcar

Release form

Solution for oral administration.

Packing

Bottle 50 ml.

Indications

The drug is used as part of complex therapy for:

- Intense physical exertion and psycho-emotional stress: to increase working capacity, stamina, reduce fatigue, including in elderly people.

- During the rehabilitation period after illnesses and surgical interventions, injuries, including to accelerate tissue regeneration.

- Therapy of chronic gastritis and chronic pancreatitis with decreased secretory function.

- Therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma and discoid lupus erythematosus).

- Mild hyperthyroidism.

- Neurological manifestations of vascular, toxic and traumatic brain lesions.

- Anorexia Nervous Syndrome.

- Diseases accompanied by a lack of carnitine or its increased loss (myopathy, cardiomyopathy, mitochondrial diseases, hereditary diseases with concomitant mitochondrial insufficiency) - to compensate for its deficiency.

- In pediatric practice (treatment of children under 3 years old under the supervision of a doctor): when nursing premature babies, newborns, after birth injury or asphyxia for children with a sluggish sucking reflex and low weight gain for children with reduced muscle tone, with insufficient development of motor and mental functions, as well as for the prevention of these disorders in “risk” children with stunting and underweight children and adolescents under 16 years old.

- In adults in sports medicine and during intensive training (during the training process when practicing aerobic performance): to improve speed-strength indicators and coordination of movements to increase muscle mass and reduce body fat mass to prevent post-workout syndrome (accelerate recovery processes after physical loads) for traumatic injuries in order to accelerate muscle regeneration.

Contraindications

Individual intolerance.

Pregnancy and lactation

Pregnancy is contraindicated due to lack of research.

It is necessary to stop breastfeeding during the period of use of the drug.

Composition

In 1 ml of oral solution contains: levocarnitine (karnifit) 300 mg.

Excipients:

citric acid monohydrate 1.2 mg,

methyl parahydroxybenzoate 0.5 mg,

propyl parahydroxybenzoate 0.2 mg,

purified water to 1 ml.

Dosage and administration of

The drug is used as part of complex therapy. Inside 30 minutes before meals, additionally diluting with liquid.

With prolonged physical and psycho-emotional stress: from 0.75 g (1/2 scoop or 2.5 ml) 3 times a day to 2.25 g (1.5 scoop or 7.5 ml) 2-3 times in a day.

In case of anorexia nervosa, as well as during the rehabilitation period after illnesses and surgical interventions and injuries: 1.5 g (1 scoop or 5 ml) 2 times a day. The course of treatment is within 1-2 months.

In the complex treatment of chronic gastritis and chronic pancreatitis with reduced secretory function: 0.375 g (1/4 scoop or 1, 25 ml) 2 times a day. The course of treatment is within 1-1.5 months.

For the treatment of skin diseases: 0.75 g (1/2 scoop or 2.5 ml). The course of treatment is within 2-4 weeks.

With mild hyperthyroidism: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or prescribed for 3 months without a break.

For vascular, toxic and traumatic brain damage: 0.75 g (1/2 scoop or 2.5 ml) per day. The course of treatment is within 3-5 days. If necessary, after 12-14 days, a second course is prescribed.

For diseases accompanied by a lack of carnitine (primary and secondary carnitine deficiency): up to 50-100 mg / kg (2-5 drops / kg) of body weight with a frequency of administration of 2-3 times a day. The course of treatment is within 3-4 months.

Children are prescribed as an additive to sweet dishes (kissel, compote, juices): for children under 3 years old, the dose is determined by the attending physician from 3 to 6 years old - in a single dose of 0.1 g (5 drops) 2-3 times a day , in a daily dose of 0.2-0.3 g (11-16 drops). The course of treatment is 1 month for children from 6 to 12 years of age prescribed in a single dose of 0.2-0.3 g (11-16 drops) 2-3 times a day, in a daily dose of 0.4-0.9 g (22- 48 drops). The course of treatment is at least 1 month.

With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or prescribed for 3 months without a break.

In sports medicine and during intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In case of use for therapeutic purposes - 70-100 mg / kg / day (5-7.5 g / day). Admission courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.

Side effects

Possible: allergic reactions, gastralgia, dyspepsia, myasthenia gravis (in patients with uremia).

Drug Interactions

Glucocorticosteroids promote the accumulation of the drug in tissues (other than the liver), other anabolic drugs increase the effect.

Overdose

Symptoms: dyspeptic disorders, myasthenic disorders (in patients with uremia).

Treatment: gastric lavage, activated carbon intake.

Storage conditions

Store in a dark place at a temperature of 15 to 25 РC.

After opening - in the refrigerator for 2 months.

The Expiration of

is 3 years.



pharmacy dispensing terms Over-the-counter

dosage form

dosage form

dosage form oral solution